BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 38185775)

  • 1. Febuxostat ternary inclusion complex using SBE7-βCD in presence of a water-soluble polymer: physicochemical characterization, in vitro dissolution, and in vivo evaluation.
    Sakran W; Abdel-Hakim M; Teiama MS; Abdel-Rashid RS
    Drug Deliv Transl Res; 2024 Jul; 14(7):1909-1922. PubMed ID: 38185775
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Preparation of meloxicam-β-cyclodextrin-polyethylene glycol 6000 ternary system: characterization, in vitro and in vivo bioavailability.
    Radia O; Rogalska E; Moulay-Hassane G
    Pharm Dev Technol; 2012; 17(5):632-7. PubMed ID: 21428700
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Development of an optimized febuxostat self-nanoemulsified loaded transdermal film:
    Alhakamy NA; Fahmy UA; Ahmed OAA; Almohammadi EA; Alotaibi SA; Aljohani RA; Alharbi WS; Alfaleh MA; Alfaifi MY
    Pharm Dev Technol; 2020 Mar; 25(3):326-331. PubMed ID: 31794286
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Formulation and biological evaluation of glimepiride-cyclodextrin-polymer systems.
    Ammar HO; Salama HA; Ghorab M; Mahmoud AA
    Int J Pharm; 2006 Feb; 309(1-2):129-38. PubMed ID: 16377107
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inclusion complex and nanoclusters of cyclodextrin to increase the solubility and efficacy of albendazole.
    Pacheco PA; Rodrigues LNC; Ferreira JFS; Gomes ACP; Veríssimo CJ; Louvandini H; Costa RLD; Katiki LM
    Parasitol Res; 2018 Mar; 117(3):705-712. PubMed ID: 29327323
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Enhancement of dissolution and oral bioavailability by adjusting microenvironment pH in crocetin ternary solid dispersions: Optimization, characterization, in vitro evaluation, and pharmacokinetics.
    Tong Z; Liu X; Tao Y; Feng P; Luan F; Jie X; Xie Z; Pu F; Xu Z; Wang P
    Drug Deliv Transl Res; 2024 Jul; 14(7):1923-1939. PubMed ID: 38117406
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of SBE7-beta-cyclodextrin complexation on carbamazepine release from sustained release beads.
    Smith JS; Macrae RJ; Snowden MJ
    Eur J Pharm Biopharm; 2005 May; 60(1):73-80. PubMed ID: 15848059
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Bioavailability enhancement of poorly water soluble and weakly acidic new chemical entity with 2-hydroxy propyl-beta-cyclodextrin: selection of meglumine, a polyhydroxy base, as a novel ternary component.
    Basavaraj S; Sihorkar V; Shantha Kumar TR; Sundaramurthi P; Srinivas NR; Venkatesh P; Ramesh M; Kumar Singh S
    Pharm Dev Technol; 2006; 11(4):443-51. PubMed ID: 17101515
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Amorphous solid dispersion studies of camptothecin-cyclodextrin inclusion complexes in PEG 6000.
    Fatmi S; Bournine L; Iguer-Ouada M; Lahiani-Skiba M; Bouchal F; Skiba M
    Acta Pol Pharm; 2015; 72(1):179-92. PubMed ID: 25850214
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Solubility and dissolution rate of progesterone-cyclodextrin-polymer systems.
    Lahiani-Skiba M; Barbot C; Bounoure F; Joudieh S; Skiba M
    Drug Dev Ind Pharm; 2006 Oct; 32(9):1043-58. PubMed ID: 17012117
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Physicochemical characteristics and bioavailability of a novel intestinal metabolite of ginseng saponin (IH901) complexed with beta-cyclodextrin.
    Lee PS; Han JY; Song TW; Sung JH; Kwon OS; Song S; Chung YB
    Int J Pharm; 2006 Jun; 316(1-2):29-36. PubMed ID: 16574357
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Improving Solubility and Oral Bioavailability of Febuxostat by Polymer-Coated Nanomatrix.
    Yin YF; Guo Y; Song WD; Duan XC; Zheng XC; Zhong T; Zhang S; Yao X; Xu MQ; Zhang Q; Zhang X
    AAPS PharmSciTech; 2018 Feb; 19(2):934-940. PubMed ID: 29079988
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Solubility enhancement of miconazole nitrate: binary and ternary mixture approach.
    Rai VK; Dwivedi H; Yadav NP; Chanotiya CS; Saraf SA
    Drug Dev Ind Pharm; 2014 Aug; 40(8):1021-9. PubMed ID: 23781847
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Solubility and Thermodynamic Data of Febuxostat in Various Mono Solvents at Different Temperatures.
    Haq N; Alghaith AF; Alshehri S; Shakeel F
    Molecules; 2022 Jun; 27(13):. PubMed ID: 35807294
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Analysis of triclosan inclusion complexes with β-cyclodextrin and its water-soluble polymeric derivative.
    Jug M; Kosalec I; Maestrelli F; Mura P
    J Pharm Biomed Anal; 2011 Apr; 54(5):1030-9. PubMed ID: 21215544
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Polymer-free electrospun nanofibers from sulfobutyl ether
    Yildiz ZI; Celebioglu A; Uyar T
    Int J Pharm; 2017 Oct; 531(2):550-558. PubMed ID: 28445768
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cyclodextrin-water soluble polymer ternary complexes enhance the solubility and dissolution behaviour of poorly soluble drugs. Case example: itraconazole.
    Taupitz T; Dressman JB; Buchanan CM; Klein S
    Eur J Pharm Biopharm; 2013 Apr; 83(3):378-87. PubMed ID: 23201048
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The formation of an inclusion complex between a metabolite of ginsenoside, compound K and γ-cyclodextrin and its dissolution characteristics.
    Igami K; Ozawa M; Inoue S; Iohara D; Miyazaki T; Shinoda M; Anraku M; Hirayama F; Uekama K
    J Pharm Pharmacol; 2016 May; 68(5):646-54. PubMed ID: 26255976
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Enhanced bioavailability of poorly water-soluble clotrimazole by inclusion with beta-cyclodextrin.
    Prabagar B; Yoo BK; Woo JS; Kim JA; Rhee JD; Piao MG; Choi HG; Yong CS
    Arch Pharm Res; 2007 Feb; 30(2):249-54. PubMed ID: 17366748
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Preferential Formulation of Second Generation Antipsychotic Asenapine as Inclusion Complex with Sulphobutylether-βCD (Captisol): In vitro and In vivo Evaluation.
    Kulkarni JA; Avachat AM; Avachat CM; Pradhan R; Suryawanshi TS; Khan EM; Martis EAF; Coutinho EC; Padhye S
    Curr Drug Deliv; 2018; 15(4):520-531. PubMed ID: 29165075
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.